Behind the Science
Behind the Science is a podcast from GSK hosted by Dr. Kat Arney. Each episode examines how current scientific discoveries are shaping future health. It features conversations with the people and ideas affecting patients, communities, and health systems worldwide. The show is produced and funded by GSK.
Episodes
Can science change the future of hepatitis B?
Experts Joyeta Das & Jessica Hicks discuss a disease that is so quiet and unassuming, it's often called 'the silent disease’ – Hepatitis B.
Developed and funded by GSK.
Show note:
In the third Behind the Science episode, Dr. Kat Arney speaks with Jessica Hicks, Senior Director of the World Hepatitis Alliance, and Joyeta Das, Senior Global Medical Director for hepatitis B at GSK, to take a c
If 400m+ people live with COPD, why aren’t we talking about it?
Experts Kaivan Khavandi and Dave Singh discuss diseases that affect a fundamental aspect of life – breathing.
Developed and funded by GSK.
Show note:
In the second Behind the Science episode, Dr. Kat Arney speaks with Professor Dave Singh, a specialist in respiratory pharmacology at the University of Manchester, and Dr. Kaivan Khavandi, Senior Vice President and Global Head of Respiratory, Immuno
Introducing: If 400m+ people live with COPD, why aren’t we talking about it?
Kaivan Khavandi & Dave Singh discuss a disease that affects a fundamental aspect of life – breathing. Episode coming soon.
Developed and funded by GSK.
Are we turning the tide on superbugs?
Experts David Payne and Alison Holmes explore one of today’s biggest health challenges - antimicrobial resistance.
Developed and funded by GSK.
Show note:
In the first Behind the Science episode, Dr. Kat Arney speaks with Professor Alison Holmes, Director of the Fleming Initiative, and David Payne, Head of Infectious Disease Research at GSK, to unpack the science, urgency and innovation behind
Introducing: Are we turning the tide on superbugs?
David Payne & Alison Holmes explore one of the biggest health challenges: antimicrobial resistance. Episode coming soon.
Developed and funded by GSK
